The curry spice curcumin attenuates beta-amyloid-induced toxicity through beta-catenin and PI3K signaling in rat organotypic hippocampal slice culture

References

• Trojanowski JQ, Lee VM. ‘Fatal attractions’ of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann N Y Acad Sci. 2000;924:62–7.
   PubMed Web of Science ®Google Scholar
• Shim YS, Morris JC. Biomarkers predicting Alzheimer's disease in cognitively normal aging. J Clin Neurol. 2011;7:60–8.
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545–55.
   PubMed Web of Science ®Google Scholar
• Verdile G, Fuller S, Atwood CS, Laws SM, Gandy SE, Martins RN. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol Res. 2004;50:397–409.
   PubMed Web of Science ®Google Scholar
• Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 2004;44:181–93.
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78:2081–7.
   PubMed Web of Science ®Google Scholar
• Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206–17.
   PubMed Web of Science ®Google Scholar
• Belkacemi A, Doggui S, Dao L, Ramassamy C. Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev Mol Med. 2011;13:e34.
   PubMed Web of Science ®Google Scholar
• Moon DO, Kim MO, Choi YH, Park YM, Kim GY. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol. 2010;10:605–10.
   PubMed Web of Science ®Google Scholar
• Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21:8370–7.
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631–52.
   PubMed Web of Science ®Google Scholar
• Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12:332–47.
   PubMed Web of Science ®Google Scholar
• Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, et al.. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther. 2008;326:196–208.
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Murase A, Yamada M. Phenolic compounds prevents Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol. 2009;175:2557–65.
   PubMed Web of Science ®Google Scholar
• Wang HM, Zhao YX, Zhang S, Liu GD, Kang WY, Tang HD, et al.. PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. J Alzheimers Dis. 2010;20:1189–99.
   PubMed Web of Science ®Google Scholar
• Lee KY, Koh SH, Noh MY, Kim SH, Lee YJ. Phosphatidylinositol-3-kinase activation blocks amyloid beta-induced neurotoxicity. Toxicology. 2008;243:43–50.
   PubMed Web of Science ®Google Scholar
• de Oliveira AC, Candelario-Jalil E, Langbein J, Wendeburg L, Bhatia HS, Schlachetzki JC, et al.. Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia. J Neuroinflammation. 2012;9:2.
   PubMed Web of Science ®Google Scholar
• Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem. 1998;273:19929–32.
   PubMed Web of Science ®Google Scholar
• Lee SM, Tole S, Grove E, McMahon AP. A local Wnt-3a signal is required for development of the mammalian hippocampus. Development. 2000;127:457–67.
   PubMed Web of Science ®Google Scholar
• Salinas PC, Zou Y. Wnt signaling in neural circuit assembly. Annu Rev Neurosci. 2008;31:339–58.
   PubMed Web of Science ®Google Scholar
• Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods. 1991;37:173–82.
   PubMed Web of Science ®Google Scholar
• Bernardi A, Frozza RL, Meneghetti A, Hoppe JB, Battastini AM, Pohlmann AR, et al.. Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1–42 in Alzheimer's disease models. Int J Nanomedicine. 2012;7:4927–42.
   PubMed Web of Science ®Google Scholar
• Frozza RL, Horn AP, Hoppe JB, Simão F, Gerhardt D, Comiran RA, et al.. A comparative study of beta-amyloid peptides Abeta1–42 and Abeta25–35 toxicity in organotypic hippocampal slice cultures. Neurochem Res. 2009;34:295–303.
   PubMed Web of Science ®Google Scholar
• Liu R, Liu W, Doctrow SR, Baudry M. Iron toxicity in organotypic cultures of hippocampal slices: role of reactive oxygen species. J Neurochem. 2003;85:492–502.
   PubMed Web of Science ®Google Scholar
• Hoppe JB, Frozza RL, Horn AP, Comiran RA, Bernardi A, Campos MM, et al.. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. J Pineal Res. 2010;48:230–8.
   PubMed Web of Science ®Google Scholar
• Suh EC, Jung YJ, Kim YA, Park EM, Lee KE. Abeta25–35 induces presynaptic changes in organotypic hippocampal slice cultures. Neurotoxicology. 2008;29:691–9.
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Varela-Nallar L, Grabowski CP, Colombres M. Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target. IUBMB Life. 2007;59:316–21.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin WK, Shi XD, Li Y. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells. Eur J Pharm Sci. 2011;42:540–6.
   PubMed Web of Science ®Google Scholar
• Crowder RJ, Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci. 1998;18:2933–43.
   PubMed Web of Science ®Google Scholar
• Cimarosti H, Zamin LL, Frozza R, Nassif M, Horn AP, Tavares A, et al.. Estradiol protects against oxygen and glucose deprivation in rat hippocampal organotypic cultures and activates Akt and inactivates GSK-3beta. Neurochem Res. 2005;30(2):191–9.
   PubMed Web of Science ®Google Scholar
• Holopainen IE. Organotypic hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticity. Neurochem Res. 2005;30:1521–8.
   PubMed Web of Science ®Google Scholar
• Noraberg J, Poulsen FR, Blaabjerg M, Kristensen BW, Bonde C, Montero M, et al.. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord. 2005;4:435–52.
   PubMedGoogle Scholar
• Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al.. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383–421.
   PubMed Web of Science ®Google Scholar
• McGeer EG, McGeer PL. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis. 2010;19:355–61.
   PubMed Web of Science ®Google Scholar
• Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W. Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011;2:e167.
   PubMed Web of Science ®Google Scholar
• Beurel E, Jope RS. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J Neuroinflammation. 2009;6:9.
   PubMed Web of Science ®Google Scholar
• Dagvadorj J, Naiki Y, Tumurkhuu G, Noman AS, Iftekar-E-Khuda I, Koide N, et al.. Interleukin (IL)-10 attenuates lipopolysaccharide-induced IL-6 production via inhibition of IkappaB-zeta activity by Bcl-3. Innate Immun. 2009;15:217–24.
   PubMed Web of Science ®Google Scholar
• Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velázquez M, Acosta-Martínez JP, Ortiz GG. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo. J Neuroimmunol. 2004;150:20–8.
   PubMed Web of Science ®Google Scholar
• Van Eldik LJ, Thompson WL, Ralay Ranaivo H, Behanna HA, Martin Watterson D. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int Rev Neurobiol. 2007;82:277–96.
   PubMed Web of Science ®Google Scholar
• Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci. 2009;34:4–20.
   PubMed Web of Science ®Google Scholar
• Garrido JL, Godoy JA, Alvarez A, Bronfman M, Inestrosa NC. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J. 2002;16:1982–4.
   PubMed Web of Science ®Google Scholar
• Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell. 1997;88:435–7.
   PubMed Web of Science ®Google Scholar
• Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005;9:59–71.
   PubMed Web of Science ®Google Scholar
• Nassif M, Hoppe J, Santin K, Frozza R, Zamin LL, Simão F, et al.. β-Amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3b, and PTEN. Neurochem Int. 2007;50:229–35.
   PubMed Web of Science ®Google Scholar